HIGHLIGHTS
- who: Yanfang Chen et al. from the University of Kansas, United States have published the research: High-intensity chemotherapy improved the prognosis of patients with high-grade B-cell lymphoma, in the Journal: (JOURNAL)
- what: This study demonstrated that HGBLR has a worse prognosis than HGBL, NOS, and high-intensity chemotherapy was an independent risk factor predicting longer OS and PFS in patients with HGBL.
- how: The authors conducted a subgroup analysis of HGBLR and HGBL NOS patients receiving different intensity chemotherapy regimens.
SUMMARY
High-grade B-cell lymphoma . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.